A site-specific polymeric drug carrier for renal disease treatment

Brich, 1992, Preparation and characterization of a water soluble dextran immunoconjugate of doxorubicin and the monoclonal antibody, J. Control. Release, 19, 245, 10.1016/0168-3659(92)90080-B Igarashi, 1992, A stable PGE1 prodrug for targeting therapy, J. Control. Release, 20, 37, 10.1016/0168-3659(92)90137-G Kopecek, 1991, Targetable polymeric anticancer drugs. Temporal control of drug activity, Ann. New York Acad. Sci., 618, 335, 10.1111/j.1749-6632.1991.tb27253.x Nishikawa, 1992, Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice, Int. J. Pharm., 85, 75, 10.1016/0378-5173(92)90136-P Yamaoka, 1995, Fate of water-soluble polymers administered via different routes, J. Pharm. Sci., 84, 349, 10.1002/jps.2600840316 Yamaoka, 1994, Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice, J. Pharm. Sci., 83, 601, 10.1002/jps.2600830432 Kamada, 2003, Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting, Nat. Biotechnol., 21, 399, 10.1038/nbt798 Brenner, 1978, Glomerular permselectivity: barrier function based on discrimination of molecular size and charge, Am. J. Physiol., 234, F455 Takakura, 1990, Disposition characteristics of macromolecules in tumor-bearing mice, Pharm. Res., 7, 339, 10.1023/A:1015807119753 Veronese, 2002, Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation, Adv. Drug Deliv. Rev., 54, 587, 10.1016/S0169-409X(02)00029-7 Hinds, 2002, Effects of PEG conjugation on insulin properties, Adv. Drug Deliv. Rev., 54, 505, 10.1016/S0169-409X(02)00025-X Kozlowski, 2001, Development of pegylated interferons for the treatment of chronic hepatitis C, BioDrugs, 15, 419, 10.2165/00063030-200115070-00001 Duncan, 1994, Polymer conjugates. Pharmacokinetic considerations for design and development, Clin. Pharmacokinet., 27, 290, 10.2165/00003088-199427040-00004 Delgado, 1992, The uses and properties of PEG-linked proteins, Crit. Rev. Ther. Drug Carrier Syst., 9, 249 Auzely-Velty, 2002, Galactosylated N-vinylpyrrolidone-maleic acid copolymers: synthesis, characterization, and interaction with lectins, Biomacromolecules, 3, 998, 10.1021/bm020035m Murthy, 2003, Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides, J. Control. Release, 89, 365, 10.1016/S0168-3659(03)00099-3 Pedder, 2003, Pegylation of interferon alfa: structural and pharmacokinetic properties, Semin. Liver Dis., 23, 19 Milas, 2003, Poly(L-glutamic acid)-pacritaxel conjugate is a potent enhancer of tumor radiocurability, Int. J. Radiat. Oncol. Biol. Phys., 55, 707, 10.1016/S0360-3016(02)04153-6 Tsutsumi, 1994, Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its anti-tumor potency, Jpn. J. Cancer Res., 85, 9, 10.1111/j.1349-7006.1994.tb02879.x Yamamoto, 2003, Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity, Nat. Biotechnol., 21, 546, 10.1038/nbt812